SCARCELL THERAPEUTICS

A revolution in the treatment of osteoarthritis Scarcell Therapeutics has developed a unique allogeneic cell therapy that regenerates damaged cartilage. Our straightforward bioproduction has been validated and our cost of goods is extremely low. Scarcell’s Gingival Fibroblasts cell therapy presents two breakthrough advances compared to competition: 1. Exceptional healing properties compared to conventional cell therapy products: • Ability to regenerate cartilage • Long-lasting therapeutic effect due to cell preservation compared to the other current cell therapies • Powerful and long-lasting anti-inflammatory activity • Allogeneic: accessible for the entire population without the need for immunosuppressive drugs 2. Highly efficient and scalable GMP bioproduction process resulting in significantly lower manufacturing costs compared to existing cell therapies (MSCs, iPS/ES, and CAR-T cells).